Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients

Figure 2 Myofibrillogenesis regulator-1 protein expression determined by immunohistochemical staining in adjacent noncancerous mucosa and gastric cancers. A: Negative expression in adjacent noncancerous mucosa (× 200). No myofibrillogenesis regulator-1 (MR-1) expression was detected; B: Negative expression in gastric cancers (× 200). No MR-1 expression was detected; C: Weak positive expression in gastric cancer (× 200); D: Moderate positive expression in gastric cancer (× 200). MR-1 protein was expressed in cytoplasm of the cells in (C) and (D).